Fibriant B.V., Has Expanded The Existing Recombinant Fibrinogen License Agreement With Bioceros B.V. For Fibrinogen Concentrates Market

 

Fibrinogen Concentrates Market

The increasing availability of fibrinogen products and rise in a number of bleeding disorders are major factors serving as a driver for the fibrinogen concentrates market. According to the Centers for Disease Control and Prevention, in the United States, Hemophilia A affects 1 in 5,000 male births. About 400 babies are born with hemophilia A each year. Fibrinogen products are widely used to treat health problems associated with fibrinogen deficiencies. Fibrinogen is a glycoprotein that helps in the formation of blood clots. Thus increasing demand for fibrinogen concentrates for treating bleeding disorders in patients is significantly contributing to the growth of the fibrinogen concentrates market.

North America is expected to lead the global fibrinogen concentrates market owing to the growing focus on the adoption of fibrinogen products in the region.  For instance, in November 2019, Octapharma USA sponsored a scientific symposium, "Fibrinogen Supplementation in Surgical Patients - New Perspectives in Acquired Fibrinogen Deficiency. Also, the high prevalence of bleeding-related disorders in the region is again fostering regional market growth.

1.      In November 2018, Swissmedic has granted marketing authorization for Octapharma’s new fibrinogen concentrate product fibryga for the treatment of congenital and acquired fibrinogen deficiencies. The key features of the product are the purity, the unaltered functionality of fibrinogen, and a high level of pathogen safety

2.      In June 2019, Grifols the providers of plasma-derived medicines to treat life-threatening diseases with Ethicon Inc. announced that the launch of VISTASEAL™ fibrin sealant   as part of a broad global relationship to provide plasma-protein-based solutions to manage surgical bleeding

3.      In December 2019, Fibriant B.V., a developer of innovative recombinant fibrin (ogen) technology and products announced that it has expanded the existing recombinant fibrinogen license agreement with Bioceros B.V. for the use of their CHOBC® expression technology and also include development and manufacturing of recombinant human (pro) thrombin.

Fibrinogen is a protein used in the circulatory system and also in bone tissue. It is also used in wound healing, as it is an excellent source of collagen, a tough, fibrous protein that makes up about twenty percent of the connective tissue in the body and is particularly effective in helping to repair wounds. Fibrinogen is produced by the body and the fibrin protein is found in collagen fibers, in blood vessels, and in the placenta. It is synthesized by the body when it is exposed to an injury or trauma. The fibrinogen in an injury is highly effective in treating the wound, but it is difficult to extract because of its highly complex molecular structure.

Comments

Post a Comment

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Image
  Whiskey or single malt whiskey is simply a form of distilled beverage made by distilling alcohol from grain mash or even by blending both. Different grains are utilized for different types, such as corn, barley, rye, and wheat. In Scotland, they call their whiskey black tea, a lighter caramel scotch, Irish cream, and liqueur. Whichever form is utilized, the result is usually a flavorful and smooth drink that has a distinct taste, and many people prefer a whiskey with a lower alcohol content. For example, single malt whiskey is the least expensive. The highest price however is the least distilled; that is Bourbon whiskey. Bourbon whiskey is the most popular whiskey in America and in many other countries around the world. Its price range is very wide, starting from as low as about US$ 12 a bottle to over a hundred dollars. So the price definitely varies. Whichever class you belong to, there is always a whiskey that will suit your preference. Single malt scotch whiskey is made ...
Read more

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Image
  Viral Vectors are proteins that have been discovered to be essential for the spread of various viruses and infectious agents. These proteins can cause serious health risks if they are improperly introduced or if a wrong agent is used to fight them off. Viral vectors have often been used in various gene therapy procedures with the ultimate objective of curing various ailments in the biological fields of neurology, gene therapy, cancer, and metabolic disorder. Clinical studies regarding viral vectors remain one of the key factors in the manufacturing of viral vectors. Plasmids are used to deliver DNA contain genes for antibiotic resistance. In fact, scientists have developed many uses of plasmids and created software to record the DNA sequences of plasmids for applications in various techniques. Thus, such continuous R&D activities can potentially stimulate growth of the viral vectors and plasmid DNA manufacturing market . Recently, in April 2021, Oxford Biomedica plc entered...
Read more

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)

Image
  There are many reasons why people choose hard surface floors over other types of flooring. Hard surfaces offer a level of durability and are very aesthetically pleasing. Unfortunately, choosing this type of flooring can be confusing and costly. There are four main hard surface varieties namely vinyl plank, laminate, solid hardwood, and engineered wood. Each has their own style strengths and provide different advantages. Increasing population coupled with rapid urbanization is expected to drive growth of the global hard surface flooring market . According to the United Nations (UN), by 2050, around 68% of the global population is expected to live in urban areas, increasing from 55% in 2018. According to the same source, in 2018, around 4.2 billion people were living in urban areas, increasing from 751 million in 1950. Furthermore, according to the World Bank, in 2019, the global population reached 7.674 billion, increasing from 6.84 billion in 2009. As a result of this, building...
Read more